| Literature DB >> 36187956 |
Chung-Jen Chiang1, Mu-Chen Hu2, Thanh Ta2, Yun-Peng Chao2,3,4.
Abstract
The economic viability of the biomass-based biorefinery is readily acknowledged by implementation of a cascade process that produces value-added products such as enzymes prior to biofuels. Proteins from the waste stream of biorefinery processes generally contain glutamate (Glu) in abundance. Accordingly, this study was initiated to explore the potential of Glu for production of recombinant proteins in Escherichia coli. The approach was first adopted by expression of D-hydantoinase (HDT) in commercially-available BL21(DE3) strain. Equipped with the mutant gltS (gltS*), the strain grown on Glu produced the maximum HDT as compared to the counterpart on glucose, glycerol, or acetate. The Glu-based production scheme was subsequently reprogrammed based on the L-arabinose-regulated T7 expression system. The strain with gltS* was further engineered by rewiring metabolic pathways. With low ammonium, the resulting strain produced 1.63-fold more HDT. The result indicates that Glu can serve as a carbon and nitrogen source. Overall, our proposed approach may open up a new avenue for the enzyme biorefinery platform based on Glu.Entities:
Keywords: enzyme biorefinery; glutamate; metabolic engineering; protein waste; recombinant proteins
Year: 2022 PMID: 36187956 PMCID: PMC9515452 DOI: 10.3389/fmicb.2022.991963
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Figure 1Schematic illustration of Glu metabolism in Escherichia coli. Related genes in metabolic pathways involve as follows: aspC, aspartate aminotransferase; aspA, Asp ammonia-lyase; glnA, glutamine synthetase; gltA, citrate synthase; gltS*, Na+/Glu symporter; pckA, phosphoenolpyruvate carboxykinases; pfkA, 6-phosphofructokinase; pgl, lactonase; ppc, PEP carboxylase; pykF, pyruvate kinase; zwf, glucose-6-phosphate dehydrogenase. Abbreviations: Ace, acetate; Asp, aspartate; CIT, citrate; F6P, fructose-6-phosphate; FDP, fructose-biphosphate; FUM, fumarate; G6P, glucose-6-phosphate; Gln, glutamine; α-KG, α-ketoglutarate; MAL, malate; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PGA, 3-phosphoglyceraldehyde; PYR, pyruvate; R5P, ribose-5-phosphate.
Figure 2The protein production for the strain using various substrates. The HDT production was conducted with BL21(DE3) strain which harbored pET-TrChHDT plasmid in the presence of various carbon sources (10 g/l). The growth of the acetate-grown strain was sustained by supplement of yeast extract (2 g/l). To grow on Glu, the strain was additionally transformed with pTH-gltS* plasmid. A typical growth profile on each substrate and the HDT production (bars) were shown for the recombinant strain. HDT was analyzed for the strain grown on glucose (Glc), glycerol (Gly), Glu, and acetate (Ace) at 11 h, 13 h, 13 h, and 27 h, respectively. The experiment was performed in triplicate and data were shown with the standard deviation.
Figure 3The protein production in Glu-dependent strain. The HDT production was conducted with BAD-HDT/pTH-gltS* strain in the presence of Glu (10 g/l). A typical growth profile and the HDT production (bar) were shown for the recombinant strain. The experiment was performed in triplicate and data were shown with the standard deviation.
Figure 4The protein production for the genetically-modified strain. The HDT production was conducted with BAD-HDT-1/pTH-gltS* strain (A) and BAD-HDT-1/pTH-gltS* strain bearing pACYC-aspA plasmid in the presence of Glu (10 g/l) (B). A typical growth profile and the HDT production (bar) were shown for the recombinant strain. The experiment was performed in triplicate and data were shown with the standard deviation.
Figure 5Improvement of the protein production in the engineered strain. The HDT production in BAD-HDT-1/pTH-gltS* and BAD-HDT-1/pTH-gltS*/pPC201 strain was carried out in the minimal medium containing Glu (20 g/l) and NH4Cl (0.35 g/l). A typical growth profile and the HDT production (bars) were shown for the recombinant strains. The experiment was performed in triplicate and data were shown with the standard deviation. Strains were designated as BAD-HDT-1 and BAD-HDT-1/pPC201 for clarity.
The summary of engineered strains applied for the HDT production.
| Strain | μ (1/h) | X (g DCW/l) | Y (U/g DCW/l) |
|---|---|---|---|
| BAD-HDT/pTH-gltS* | 0.25 ± 0.01 | 1.42 ± 0.06 | 53.5 |
| BAD-HDT-1/pTH-gltS* | 0.27 ± 0.02 | 1.82 ± 0.06 | 59.3 |
| BAD-HDT-1/pTH-gltS*/pPC201 | 0.23 ± 0.01 | 3.30 ± 0.08 | 60.6 |
Engineered strains were applied for the HDT production based on Glu. Their specific growth rate (μ), final biomass (X), and specific HDT yield (Y) were summarized in the Table. DCW, dry cell weight.